A worldwide shortage of diesel and jet fuel is forcing a reorganization of the global economy, leading to deglobalization and ...

Elon Musk said Tesla's Model X and Model S — the company's highest-priced cars — are getting the ax. While Tesla doesn't specify how many were sold, earnings show demand has been falling for years.

The Quickest Way to Mix With SSL EQ & ComprDiscover the fastest way to get a clean, professional mix using SSL EQ and compression with SSL Auto plugins. This workflow shows how automatic gain, smart ...

Gentex faces ongoing headwinds from an adverse mix shift and still-weak underlying global auto-build rates. GNTX's core auto-dimming mirror business is underpenetrated, but adoption has stalled in ...

What makes a large language model like Claude, Gemini or ChatGPT capable of producing text that feels so human? It’s a question that fascinates many but remains shrouded in technical complexity. Below ...

But they say a lack of empirical data and other flaws in the NEPTUNE model raise concerns that "temper our enthusiasm for the model and our confidence that it can provide a comprehensive explanation ...

What happens when artificial intelligence becomes too eager to please? Imagine asking an AI for advice, only to realize later that its response was more about agreeing with you than offering accurate ...

Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal films, but audiences are divided over its cryptic ending and philosophical twist ...

Nvidia launched the new version of its frontier models, Nemotron 3, by leaning in on a model architecture that the world’s most valuable company said offers more accuracy and reliability for agents.

A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic predispositions and environmental exposures converge to cause autism spectrum ...

Tempus AI TEM operates at the intersection of clinical genomics and AI-driven insights. Its testing and data products are gaining traction with providers and biopharma partners. With revenue up ...